Introduction
The 2026 mega-IPO wave is the deepest in modern ECM history. SpaceX, OpenAI, Anthropic, Databricks, Cerebras, and several other unicorn-tier issuers are all listing or preparing to list, with combined potential demand of $100 to $200 billion (more than the entire 2025 US IPO market). SpaceX has already cleared the gate: after a confidential S-1 filed April 1, 2026 ("Project Apex"), it priced its IPO on June 11 at $135 per share, raising $75 billion to shatter Saudi Aramco's $29.4 billion 2019 record, and begins trading on Nasdaq under ticker SPCX on June 12 at a roughly $1.77 trillion market capitalization. Behind it, Anthropic, freshly valued at $965 billion in a late-May private round, and OpenAI, last privately valued near $852 billion, have both filed confidential S-1s targeting public listings later in 2026, while Databricks is reportedly eyeing a $175 billion valuation and Cerebras filed to compete in AI chips. The wave's depth represents a generational franchise opportunity and a structural setup that could produce one of the largest annual ECM volume years on record.
Why the Mega-IPO Window Reopened Now
The 2026 wave did not appear from nowhere. It is the release of pressure that built through a multi-year freeze. After the 2021 IPO boom, the market essentially shut: the 2022-2023 rate shock drove the IPO window into its deepest drought in over a decade, and only 17 venture-backed unicorns went public in 2025. The result was an unprecedented logjam of more than 800 private unicorns sitting on a combined $4.3 trillion of locked value, with employees, early investors, and limited partners all waiting for liquidity that private secondary markets could only partly provide.
Several forces converged to crack the window open. Rate stabilization removed the single biggest source of valuation uncertainty: with the Federal Reserve having eased to a stable 3.50-3.75% and holding, both issuers and public investors could price growth assets with far more confidence than during the 2022-2023 tightening cycle. The AI capital-expenditure supercycle simultaneously created a cohort of companies with genuinely insatiable funding needs: training frontier models and building data-center compute requires tens of billions in capital that even the deepest private rounds struggle to supply, pushing the largest AI names toward public markets as a matter of necessity rather than choice.
Just as important, the top of the backlog used the freeze productively. Rather than rushing out at 2021-style valuations, the strongest candidates spent 2023 to 2025 building public-company financial infrastructure, tightening governance, and in several cases reaching profitability, producing a pipeline more mature than the 2021 cohort. By early 2026, the signal was unmistakable: the first quarter marked the strongest opening for US IPOs in five years, and IPO proceeds over the trailing twelve months had grown roughly 84%. When SpaceX, Anthropic, and OpenAI all moved within the same window, the reopening became a flood.
SpaceX: The Headline 2026 IPO
SpaceX's IPO is the centerpiece of the 2026 pipeline.
- Mega-IPO
An IPO transaction at exceptional scale (typically $5 billion+ of proceeds and/or $50 billion+ market cap at pricing). Mega-IPOs require dedicated institutional capital absorption, multi-bank syndicates with substantial distribution depth, cornerstone investor anchoring, and careful calendar staggering. Recent benchmarks: SpaceX 2026 ($75B, the new record), Saudi Aramco ($29.4B in 2019), Alibaba ($25B in 2014).
Filing, Valuation, and Pricing
SpaceX filed a confidential S-1 with the SEC on April 1, 2026, codenamed "Project Apex," targeting a $1.75 trillion valuation (up from $1.25 trillion when SpaceX merged with xAI in February 2026). On June 11, 2026, it priced the deal at $135 per share (555,555,555 shares), raising $75 billion and surpassing Saudi Aramco's $29.4 billion 2019 IPO as the largest in history by nearly 3x. The pricing valued SpaceX at roughly $1.77 trillion, making it the seventh-largest US public company at debut, ahead of Tesla (around $1.6 trillion).
Roadshow, Bookrunners, and Retail Allocation
SpaceX ran an abbreviated roadshow the week of June 8, 2026, with approximately 125 financial analysts from the 21 banks on the deal meeting the company before launch and a major event hosting roughly 1,500 retail investors on June 11. Shares begin trading on Nasdaq under ticker SPCX on June 12. Lead active bookrunners are Morgan Stanley, BofA, Citi, JPMorgan, and Goldman Sachs, with 16 other banks in smaller roles. SpaceX CFO Bret Johnsen indicated retail would be a bigger part than any IPO in history, with the company signaling an unprecedented retail allocation far above the typical Wall Street norm. SpaceX listed the entire company as one public entity rather than spinning off Starlink, combining launch services, Starlink, Starshield, and the merged xAI assets into a single listing.
Valuing a Company That Has Never Traded
Pricing SpaceX at roughly $1.77 trillion required valuing three very different businesses bundled into one listing, with no clean public comparable for the whole. The natural approach is sum-of-the-parts: value the launch business on its manifest and contract backlog, value Starlink as a high-growth subscription and connectivity business (the segment most investors treat as the real engine of the valuation), value Starshield on its government and defense contracts, and value the merged xAI assets on the same frontier-AI logic driving the rest of the 2026 pipeline. Each segment pulls toward a different methodology: launch and Starshield lean on contract-backed cash flow, Starlink on subscriber and ARPU-driven growth multiples, and xAI on the revenue-multiple and strategic-scarcity framing applied to OpenAI and Anthropic.
The difficulty is that bundling them into a single public entity, rather than spinning off Starlink, forces investors to underwrite the whole conglomerate at once and accept management's capital-allocation choices across wildly different businesses. Bulls argue the combination captures real synergies (Starlink funds launch, launch enables Starlink, xAI consumes the compute) and that a single mega-cap is easier to index and own. Skeptics counter that a conglomerate structure can mask weaker segments behind the strongest one and invite a discount over time. For an ECM analyst, SpaceX is a live case study in why issuers list combined or separated, and how that single choice shapes both the valuation narrative and the investor base it attracts.
How Mega-IPOs Get Executed
A $75 billion offering is not simply a larger version of a normal IPO; the mechanics change at scale. The defining challenge is absorption: no single investor, and no small syndicate, can place tens of billions of new equity into the market in a single morning. This is why the SpaceX deal carried 21 banks rather than the three or four a typical large-cap IPO uses. The syndicate is a distribution machine, with each bank responsible for placing stock with its own institutional relationships while the lead active bookrunners coordinate the book and the remaining banks broaden reach.
Several execution levers become essential at this scale:
- Cornerstone and anchor investors. Sovereign wealth funds and large long-only managers commit to take sizable blocks before the deal opens, providing a demand foundation that de-risks the book. For a deal the size of SpaceX, multi-billion-dollar cornerstone commitments are not optional; they are the structural anchor that makes the rest of the book possible.
- Price discovery for never-public assets. A company like SpaceX has no trading history and few true comparables, so the syndicate must build a valuation case from first principles across launch, Starlink, and the merged xAI assets, then test it through extensive pre-marketing before a price range is even set.
- Calendar staggering. With multiple mega-deals competing for the same pool of allocator capital, banks must space bookbuilds so two giants are not marketing into the same week. This is why the 2026 sequence runs SpaceX in June, OpenAI targeting September, and Anthropic October rather than bunching them.
- Stabilization and the greenshoe. At $75 billion, the over-allotment option and post-pricing stabilization are critical tools for supporting the stock in early trading, where even a modest percentage swing represents billions in value.
The unifying theme is that mega-IPO execution is fundamentally a problem of distribution capacity and risk staging, not valuation alone. The valuation debate gets the headlines, but the reason these deals require armies of banks and months of cornerstone work is that placing this much stock without breaking the aftermarket is genuinely hard. The contrast with a conventional offering shows just how different the playbook becomes.
| Feature | Typical Large-Cap IPO | SpaceX Mega-IPO |
|---|---|---|
| Proceeds raised | $500M-$3B | $75 billion |
| Banks in syndicate | 3-6 | 21 |
| Cornerstone reliance | Helpful | Essential |
| Retail allocation | ~10% | ~30% (signaled) |
| Comparable companies | Several public peers | Few or none |
For candidates, the lesson is to resist treating a mega-IPO as just a bigger headline number. The size is precisely what forces a different execution model, and an interviewer who asks why SpaceX needed 21 banks is testing whether you understand distribution, not arithmetic.
The Retail Allocation Revolution
The most unusual structural feature of the SpaceX IPO was its embrace of retail investors. Where a typical large-cap IPO reserves roughly 10% of shares for retail, SpaceX signaled an allocation as high as 30%, or roughly $22.5 billion of the offering, three times the Wall Street norm and the largest retail push in IPO history. The company made shares available to individual investors through major brokerages including Charles Schwab, Fidelity, Robinhood, SoFi, and E*TRADE, with eligibility ranging from no account minimum at several platforms to a $100,000 liquid net worth requirement at others.
The rationale is part brand, part strategy. SpaceX is a rare consumer-recognizable name with a passionate following, and channeling that enthusiasm into the shareholder base both broadens distribution and creates a built-in base of long-term holders less likely to sell early. For the bankers, a large retail tranche is also a genuine distribution tool: it absorbs supply that the institutional book alone might strain to take at the target price, particularly on a deal reported to be roughly 3.3x oversubscribed.
OpenAI, Anthropic, and the AI Pipeline
The AI sub-segment of the 2026 pipeline is structurally important.
OpenAI and Anthropic
OpenAI filed a confidential S-1 on June 8, 2026. Its last private round valued it near $852 billion on roughly $25 billion of annualized revenue; reporting puts its IPO target in the $730-850 billion range, notably at or below that private mark, for a debut as early as September 2026, with Goldman Sachs and Morgan Stanley underwriting. The IPO valuation itself will not be set until pricing. Anthropic filed its own confidential S-1 on June 1, 2026. Its late-May Series H raised $65 billion at a $965 billion private valuation, briefly eclipsing OpenAI in private-market value, and it is targeting an October 2026 listing expected to raise $60 billion+, with Goldman Sachs, JPMorgan, and Morgan Stanley leading. As with OpenAI, the actual IPO valuation remains unknown until the deal prices.
Combined AI Pipeline
That OpenAI and Anthropic filed confidential S-1s within a single week (June 1 and June 8) is itself a landmark: the two leading frontier AI labs are racing toward the public markets in parallel, each at a valuation that would have been the largest tech IPO in history only a year earlier. The sequencing matters because both are advised by overlapping syndicates anchored by Goldman Sachs and Morgan Stanley, so the banks must stagger bookbuilds carefully to avoid having the two deals compete for the same allocator dollars in the same window. Combined SpaceX + OpenAI + Anthropic + Databricks demand is estimated at $100 to $200 billion, more than the entire 2025 US IPO market, representing a generational allocation opportunity for institutional investors and a once-in-a-cycle league-table prize for the lead bookrunners.
Databricks, Cerebras, and Adjacent Issuers
Beyond the headline AI mega-IPOs, several adjacent issuers round out the 2026 pipeline.
April 2026
SpaceX confidential S-1 ("Project Apex") filed; $1.75T valuation target; 21-bank syndicate.
June 1, 2026
Anthropic files confidential S-1 at a $965B private valuation.
June 8, 2026
OpenAI files confidential S-1; abbreviated SpaceX roadshow underway.
June 11-12, 2026
SpaceX prices at $135/share, raises $75B (record), begins trading as SPCX; first 2026 mega-IPO sets the tone.
Q3 2026
OpenAI targets a September debut; Databricks and adjacent issuers sequence as the calendar permits.
Q4 2026
Anthropic targets an October listing; Cerebras, Stripe, and others follow as conditions allow.
Year-End 2026
If the wave executes cleanly, US IPO volume could approach or exceed $100-150 billion, multiples of the 2025 total.
Databricks, Cerebras, Kraken, Stripe
Databricks is the only profitable name in the AI cohort ($5.4B annualized revenue, 65 percent YoY growth, positive FCF, net retention above 140 percent) and is reportedly eyeing a $175 billion valuation, up from the $134 billion at which it raised $7 billion of equity and debt in early 2026; the CFO has indicated "ready when it decides" without a fixed 2026 date. Cerebras Systems filed its S-1 positioning as an Nvidia chip alternative. Crypto exchange Kraken filed for a $20 billion listing extending the 2025 crypto-IPO cohort (Circle, Bullish, eToro), but suspended its IPO plans in March 2026 amid difficult market conditions, with its valuation reportedly resetting to roughly $13.3 billion. Stripe ($90 billion+ in its early 2025 buyback) is "in no rush" given profitability and secondary-market liquidity. Revolut ($75B confirmed funding-round valuation), Canva (most recent confirmed private valuation around $42B in 2025, with bull-case IPO estimates reaching $60-100B), and Shein ($50B) round out the international pipeline.
Risks and the Down-Round Question
For all its momentum, the 2026 wave carries real risk, and the central one is capacity. Combined potential demand of $100 to $200 billion across the largest deals exceeds the entire 2025 US IPO market by several multiples. Even deep institutional pools have limits, and allocators forced to choose among SpaceX, OpenAI, Anthropic, and Databricks may spread commitments thin or sit out later deals if the first few disappoint. The calendar is therefore self-reinforcing in both directions: a clean SpaceX debut builds confidence for the names behind it, while a weak aftermarket could close the window as quickly as it opened.
- Down-Round IPO
An initial public offering priced at or below the company's most recent private funding-round valuation. Once rare for marquee names, down-round (or flat) IPOs grew more common after 2022 as public investors applied stricter discipline than the late-stage private and crossover funds that had bid valuations up. A down-round IPO is not necessarily a failed deal; it can still raise enormous capital, but it signals that public markets are repricing the asset below its last private mark.
The subtler risk is valuation. The most telling detail in the AI pipeline is that OpenAI's reported IPO target sits at or below its last private valuation of roughly $852 billion. A flat-to-down IPO relative to the last private round, once almost unheard of for a marquee name, reflects a public market that is more disciplined than the late-stage private rounds that preceded it. Public investors apply scrutiny that crossover and venture funds, racing to own a piece of the AI frontier, did not. For companies that raised at peak private valuations, the IPO can become a moment of repricing rather than celebration, and the gap between the private mark and the clearing price is exactly where money is left on the table in either direction.
The 2026 mega-IPO wave above is the most structurally important component of the 2026 ECM outlook. The next article walks through the PE-backed sponsor IPO backlog, where the multi-year build-up of aging sponsor-backed assets is driving sustained 2026 IPO and follow-on activity beyond the mega-IPO headlines.


